Inturai Ventures (CSE:URAI) Announces OTC Ticker Change, European Trading, and Accelerated Military Strategy

VANCOUVER, BC — January 13, 2026 — Leads & Copy — Inturai Ventures Corp. (CSE: URAI) (OTC: URAIF) (FSE: 3QG) has announced that its U.S. OTCQB Venture Market trading code has changed to URAIF. The company also confirmed that its shares are now listed and tradable on Trade Republic in Germany. In addition, Inturai Ventures is actively evaluating opportunities to accelerate its North American military and defence strategy.

The ticker change is now effective and applies to all U.S. over-the-counter market trading, aligning its U.S. market presence with its global identity. The OTCQB listing is expected to enhance visibility, liquidity and accessibility for U.S.-based investors trading in U.S. dollars during U.S. market hours. The OTCQB quotation is expected to impose no additional material compliance or reporting requirements.

As a foreign issuer, Inturai Ventures Corp will continue to meet its existing primary market disclosure obligations, which satisfy OTC market requirements under established foreign issuer exemptions. The Company’s primary listing and regulatory framework remain unchanged.

Management views the OTCQB ticker update to URAIF as timely which supports increasing engagement from North American investors and stakeholders. Aligning the Company’s name, ticker, and U.S. trading platform strengthens clarity in the market and positions Inturai Ventures Corp. for broader participation as U.S. awareness and interest continue to build.

The inclusion on Trade Republic provides streamlined access for German and broader European investors, further expanding the Company’s international reach and improving ease of participation across major capital markets. The availability of Inturai Ventures Corp shares on Trade Republic complements the Company’s existing listings and supports its strategy to broaden global investor access through trusted, high-volume trading platforms.

The company is actively evaluating opportunities to accelerate its North American military and defence strategy, building on increasing inbound interest from U.S. based defence, government and allied industry stakeholders. This evaluation includes potential team expansion, partnerships, pilot programs and commercial pathways to support faster adoption of the Company’s technology in military and national security use cases. Any such acceleration would be pursued in a disciplined manner, consistent with Inturai Ventures Corp’s strategic objectives.

Inturai Ventures has engaged Plutus Invest & Consulting GmbH to provide online marketing content for the Company for marketing activities to design and implement an advertisement-based investor awareness campaign focused on the European investment market. The agreement commences on January 19th 2026 and ends on April 19th 2026. The Company has paid Plutus a set-up fee of Euro12,500 with a total amount of Euro25,000 per month for these services. Compensation payable to Plutus does not include any securities of the Company.

Plutus Invest & Consulting GmbH can be contacted at Buchstrasse 13, Bremen 28195, Germany or care of Marco Messina, Managing Director, via email info@plutusconsgroup.com.

Inturai Ventures is advancing intelligent environments with cutting-edge AI technologies, transforming industries such as healthcare, military, smart homes, and industrial applications.

Contact: investor@inturai.com

Source: Inturai Ventures Corp.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.